Share

August 08, 2017; 89 (6) Clinical/Scientific Notes

Wrist sensor reveals sympathetic hyperactivity and hypoventilation before probable SUDEP

Rosalind W. Picard, Matteo Migliorini, Chiara Caborni, Francesco Onorati, Giulia Regalia, Daniel Friedman, Orrin Devinsky
First published July 12, 2017, DOI: https://doi.org/10.1212/WNL.0000000000004208
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
308

Share

Article Information

vol. 89 no. 6 633-635
DOI: 
https://doi.org/10.1212/WNL.0000000000004208
PubMed: 
28701502
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received December 11, 2016
  • Accepted in final form May 1, 2017
  • First Published July 12, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Rosalind W. Picard, ScD,
    2. Matteo Migliorini, PhD,
    3. Chiara Caborni, MSc,
    4. Francesco Onorati, PhD,
    5. Giulia Regalia, PhD,
    6. Daniel Friedman, MD and
    7. Orrin Devinsky, MD
  1. Rosalind W. Picard, ScD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker travel expenses and/or honorarium from: ACM IUI, Seoul Digital Forum Korea, Trinity Institute, Society for Ambulatory Assessment, EmTech, CogSci, International Symposium on Pervasive Computing Paradigms for Mental Health, Scripps Mhealth, IEEE BCTM, Current Trends in Autism, University of PA, IEEE HCI, Veritas Forum (Georgia Tech, Harvard Medical School), Continuum, NIH, NIMH, Profectum, ETH Zurich, University of Bern, Florida International University, Lennox- Gastaut Society Foundation, XTech, NeuroTech, Body Sensor Networks, FDA OSEL, Santa Fe Institute, University of Florida, IEEE ISWC, ACM UBICOMP, Roanoke College, University of Notre Dame, Brown University, American Neuromodulation Society, USGov MITRE, ACM AAAI, Imperial College London, Deloitte, and Wharton/U Penn.

    Editorial Boards:

    1. IEEE Journal Biomedical and Health Informatics, Guest Editor Special Issue, 2014-2015

    Patents:

    1. (1) Patents related to the sensing of affective physiological data and to how autonomic data can characterize peri-ictal events

    Publishing Royalties:

    1. (1) Affective Computing, MIT Press, 1997-present

    Employment, Commercial Entity:

    1. (1) MIT Media Lab, Professor, since 1991 (2) Empatica, Chief Scientist and Chairman, since 2014

    Consultancies:

    1. (1) Empatica (2) Consultant for Apple & Intel as expert witness (see list below)

    Speakers' Bureaus:

    1. (1) SternStrategy

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Media Lab Member Consortium at MIT (2) MedImmune (3) Takeda/Millennium (4) Deloitte (5) Steelcase (6) NEC (7) Cisco (8) LKK (9) Bose

    Research Support, Government Entities:

    1. (1) NIH (R01GM105018) PI on Subcontract, 2013-2018

    Research Support, Academic Entities:

    1. (1) Mass General Hospital/MIT Challenge Award (2) University of Cambridge RG-70353 Marie Curie Award (3) University of Passau

    Research Support, Foundations and Societies:

    1. (1) Simons Foundation Autism Research Initiative (2) Robert Wood Johnson Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. Empatica Board of Directors, Travel expenses

    License fee payments, Technology or Inventions:

    1. (1) Affective computing technology patents owned by MIT, payment of sublicense fees by Affectiva

    Royalty Payments, Technology or Inventions:

    1. (1) MIT Case no 12957T entitled Wearable Physiological Sensing System with Wireless Communication, 2011- (2) MIT Case no 13335T entitled Apparatus for Real-time and Offline Measurement, Quantifying, Tagging, and Prediction of Person(s) Experiences, 2011- (3) MIT Case no 14177TK entitled An Automated Method for Simultaneous Measurement of Multi-User Physiological Parameters from Digital Color Video, 2011- (4) MIT Case no 13146T entitled A Multi-Modal Affective- Cognitive Technique for Product Evaluation with Computational Models for Predicting Customer Decision, 2011-

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. (1) Affectiva, 2009-present (2) Empatica, 2013-present

    Legal Proceedings:

    1. Intel, consultant and expert witness Apple, consultant and expert witness

  2. Matteo Migliorini, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. empatica inc, data scientist, 2

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. Empatica Inc

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Chiara Caborni, MSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Empatica Inc., data scientist, 2

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. Empatica Inc., 1

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Francesco Onorati, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Empatica, Data Scientist, 2014-till now

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. (1) Empatica, 2015-till now

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Giulia Regalia, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Empatica Inc, data scientist, 2015-now

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. (1) Empatica Inc, 2015-till now

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Daniel Friedman, MD and
    7. Scientific Advisory Boards:

    1. 1) Marmo Health, scientific advisory board 2) Supernus, advisory board

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Neuropace, speaker honorarium 2) Liva Nova, speaker honorarium

    Editorial Boards:

    1. NONE

    Patents:

    1. 1) Minimally invasive long term seizure monitor

    Publishing Royalties:

    1. Dr. Friedman receives royalties from the sale of What Do I Do Now: Epilepsy (Oxford University Press, 2011)

    Employment, Commercial Entity:

    1. Dr. Friedman receives salary support from The Epilepsy Study Consortium, a non-profit organization dedicated to improving the lives of epilepsy patients, and devotes 18% of his time to work done for the Consortium, supported by payments made by the Consortium to NYU. The Consortium receives payments from a large number of pharmaceutical companies for consulting activities. All payments are made to The Consortium and not to Dr. Friedman directly. Within the past year, the Epilepsy Study Consortium received payments from the companies listed below. All payments are reported annually and reviewed by NYU?s Conflict of Interest Committee. Accorda Pharmaceuticals, Alezxa Pharmaceuticals, GW Pharmaceuticals Eisai Medical Research, Pfizer, SK Life Science, Pfizer, Upsher Smith and Zynerba.

    Consultancies:

    1. 1) Cyberonics 2) UCB, Inc 3) GW Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. UCB Biosciences Inc

    Research Support, Government Entities:

    1. 1) NINDS, Site-PI; R01 NS084142 2013-2018 2) NINDS, Site-PI; U01 NS090407 2014-2019 3) NINDS, Co-I; U01 NS090415 2014-2019 4) CDC, Co-I; SIP U48DP005008 2014-2019 5) NIMH, Co-I ; R01MH107396 2015-2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Epilepsy Foundation, FACES (finding a cure for epilepsy and seizures).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Orrin Devinsky, MD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Cognitive and Behavioral Neurology; Oxford University Press, 2002 Epilepsy: Patient and Family Guide, Demos Press, 2008 Alternative Therapies for Epilepsy, Demos Press, 2012 Epilepsy In Children, Demos Press, 2015

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Scientific Advisory Board for Pairnomix, Egg Rock, and Tilray. Principal Investigator, North American SUDEP Registry and Sudden Unexplained Childhood Death Registry and Research Collaborative

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Ongoing Support NIH U01 NS090407 (PI: S. Lhatoo) 09/30/14 ? 7/31/2019 Center for SUDEP Research: Autonomic and Imaging Biomarkers of SUDEP The principal aim is to identify the central mechanisms and markers of autonomic and respiratory dysfunction that underlie the fatal scenario in SUDEP, and thus, provide insights into potential interventions. Role: Co-Investigator NIH U01 NS090415 (PIs: M. Thom, O. Devinsky) 9/30/14 ? 7/31/2019 Center for SUDEP Research: The Neuropathology of SUDEP: The central autonomic network, serotonin and adenosine The proposed studies will leverage the world?s largest collection of SUDEP brains to explore the role of specific histopathological and biomolecular abnormalities in the brain, focusing on critical brainstem regions and the neurotransmitters serotonin and adenosine. Role: PI National Center for Chronic Disease Prevention and Promotion U48 DP 005008-01S4 (PIs: T. Spruill, O. Devinsky) 9/1/2014 ? 8/31/2019 Managing Epilepsy Well: Adapting Project UPLIFT for Hispanic Adults with Epilepsy This project proposes to translate and culturally tailor Project UPLIFT for Hispanic patients, then test and disseminate the Spanish version. Project UPLIFT is an evidence-based intervention that incorporates cognitive behavioral and mindfulness techniques to reduce depression in adults with epilepsy. Role: Co-Investigator NIH R01 EB 018308 (PIs: K.T. Block, H. Chandarana) 9/1/2014 - 8/31/2019 Comprehensive Motion-Robust Pediatric MR Imaging Using Radial Acquisitions The proposed project aims to develop novel motion-robust magnetic resonance imaging techniques and evaluate them in clinical studies for imaging of pediatric patients with Tuberous Sclerosis. Role: Co-Investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Pairnomix - Stock Tilray - Stock Egg Rock - Stock

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Massachusetts Institute of Technology (R.W.P.); Empatica, Inc. (R.W.P., M.M., C.C., F.O., G.R.), Cambridge, MA; and NYU Langone School of Medicine (D.F., O.D.), New York, NY.
  1. Correspondence to Dr. Picard: picard{at}media.mit.edu
View Full Text

Article usage

Article usage: July 2017 to May 2023

AbstractFullPdfSource
Jul 20171963051Highwire
Aug 20175743543Highwire
Sep 20171041413Highwire
Oct 2017183106Highwire
Nov 201714048Highwire
Dec 2017144126Highwire
Jan 2018174138Highwire
Feb 2018289610Highwire
Mar 20189474Highwire
Apr 20181031019Highwire
May 20187295Highwire
Jun 20188432Highwire
Jul 201859510Highwire
Aug 20187135Highwire
Sep 20185814Highwire
Oct 20184952Highwire
Nov 20186645Highwire
Dec 20185034Highwire
Jan 20193023Highwire
Feb 20195302Highwire
Mar 20194063Highwire
Apr 20196164Highwire
May 20196623Highwire
Jun 20193032Highwire
Jul 20193921Highwire
Aug 20194021Highwire
Sep 20194723Highwire
Oct 20196114Highwire
Nov 20195913Highwire
Dec 20196311Highwire
Jan 20206273Highwire
Feb 20205422Highwire
Mar 20204722Highwire
Apr 20203421Highwire
May 20204600Highwire
Jun 20206523Highwire
Jul 20203500Highwire
Aug 20202311Highwire
Sep 20204931Highwire
Oct 20204944Highwire
Nov 20204121Highwire
Dec 20207324Highwire
Jan 20215254Highwire
Feb 20215212Highwire
Mar 20214546Highwire
Apr 20214010Highwire
May 20216333Highwire
Jun 20214354Highwire
Jul 20215074Highwire
Aug 20216431Highwire
Sep 20212511Highwire
Oct 20214611Highwire
Nov 20215212Highwire
Dec 20215013Highwire
Jan 20224421Highwire
Feb 20226314Highwire
Mar 20222835Highwire
Apr 20225011Highwire
May 20224311Highwire
Jun 20221300Highwire
Jul 20222301Highwire
Aug 20223101Highwire
Sep 20223611Highwire
Oct 20225602Highwire
Nov 20223100Highwire
Dec 20222210Highwire
Jan 20234300Highwire
Feb 20232700Highwire
Mar 20235232Highwire
Apr 20232811Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles